This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Nanosphere

Another under-$10 stock in the biotechnology and drugs complex that's setting up to trigger a major breakout trade is Nanosphere (NSPH - Get Report), which is engaged in developing, manufacturing and marketing of molecular diagnostics platform, the Verigene System, which enables sensitive genomic and protein testing on a single platform, including both genomic and protein assays, from a single sample. This stock has been soaring so far in 2012, with shares up a whopping 144%.

>>5 Stocks Insiders Love Right Now

If you take a look at the chart for Nanosphere, you'll see that this stock has been uptrending extremely strong for the last six months, with shares soaring from a low of $1.51 to its recent high of $3.89 a share. During that monster uptrend, shares of NSPH have consistently made higher lows and higher highs, which is bullish technical price action. This stock just recently spiked big right off its 50-day moving average of $3.28 a share. That spike is has now pushed NSPH within range of triggering a major breakout trade.

Market players should now look for long-biased trades in NSPH as long as it's trending above its 50-day, and then once it manages to trigger a break out above some near-term overhead resistance levels at $3.64 to $3.89 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 1,185,590 shares. If NSPH can trigger that breakout soon, then look for this stock to tag its next significant overhead resistance levels at $4.50 to $5.50 a share.

Traders can now look to buy NSPH off any weakness as long as it's trending above its 50-day at $3.28 a share, and simply anticipate that breakout. You could also buy off strength once NSPH clears those breakout levels with volume, and simply use a stop at around $3.50 a share.

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ATEC $1.36 0.37%
NSPH $3.71 -2.90%
MWW $6.15 -2.50%
NCQ $0.62 4.20%
PSTI $2.85 -0.35%

Markets

DOW 18,218.71 -67.03 -0.37%
S&P 500 2,130.88 +0.06 0.00%
NASDAQ 5,101.8630 +11.0690 0.22%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs